Evidence map›Paper›PMID 41573657›Full record

ArticleFrontiers in oncology2025

Development and validation of multiple machine learning algorithms for differentiating primary central nervous system lymphoma from adult-type diffuse glioma: an interpretable and multicenter study.

Yuanzi Liang, Junqi Hu, Tianhui Wu, Dong Bai, Zhiqun Wang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuanzi LiangDepartment of Radiology, Aerospace Center Hospital, Beijing, China.
Junqi HuDepartment of Nephrology, Aerospace Center Hospital, Beijing, China.
Tianhui WuDepartment of Medical Imaging Center, Affiliated Hospital of Inner Mongolia Minzu University, Tongliao, China.
Dong BaiDepartment of Radiology, Aerospace Center Hospital, Beijing, China.
Zhiqun WangDepartment of Radiology, Aerospace Center Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Preoperative differentiation of primary central nervous system lymphoma (PCNSL) from adult-type diffuse glioma(ADG) is important to guide neurosurgical decision-making.To develop and validate a MRI-based interpretable radiomic-clinical(Rad-Clinic) fusion model to differentiate PCNSL from ADG by seven machine learning algorithms. Methods: In this retrospective study, we recruited 165 patients who underwent preoperative conventional MRI(CET1WI, FLAIR, DWI, ADC) with PCNSL and ADG from two institutions (115 in the training cohort and 50 in the external validation cohort). we selected seven machine learning algorithms to construct a framework incorporating radiomic features and clinical parameters. SHapley Additive exPlanations (SHAP) values elucidated feature contributions, and a radiomic nomogram was developed for clinical translation. Results: The CET1WI+DWI+FLAIR fusion model exhibited optimal performance among all the single-sequence and multi-sequence radiomic models, and the AUC for external validation cohort were 0.871. But the Rad-Clinic fusion model performed well in differentiating PCNSL from ADG, and the AUC for the training and external validation cohort were 0.973 and 0.940, outperforming radiomic model and clinical model.SHAP summary plot illustrated the feature's value affected the feature'simpact attributed to the Rad-Clinic fusion model.The nomogram demonstrated clinical interpretability through visualised risk stratification. Conclusion: An interpretable Rad-Clinic fusion model enables accurate preoperative to differentiate PCNSL from ADG, and may assist improve clinical decision-making.

Indexed as

adult-type diffuse gliomaInterpretabilitymachine learningMRIprimary central nervous system lymphoma

Identifiers

PMID41573657
PMCPMC12819316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.